These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2561573)

  • 1. A human-human hybridoma which produces antibodies to polioviruses.
    Chu CT; Yang SY; Yang CS
    Proc Natl Sci Counc Repub China B; 1989 Oct; 13(4):284-8. PubMed ID: 2561573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies to polioviruses. Production of specific monoclonal antibodies to the Sabin vaccine strains.
    Osterhaus AD; van Wezel AL; van Steenis B; Drost GA; Hazendonk TG
    Intervirology; 1981; 16(4):218-24. PubMed ID: 6177658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of monoclonal antibodies prepared with Sabin vaccine viruses for the characterization of poliovirus strains isolated in Canada.
    Wachmann B; Henning D; Armstrong R; Boucher DW; Contreras G; Furesz J
    Dev Biol Stand; 1984; 57():141-9. PubMed ID: 6084605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poliovirus Sabin type 1 neutralization epitopes recognized by immunoglobulin A monoclonal antibodies.
    Fiore L; Ridolfi B; Genovese D; Buttinelli G; Lucioli S; Lahm A; Ruggeri FM
    J Virol; 1997 Sep; 71(9):6905-12. PubMed ID: 9261417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping of type 1 poliovirus neutralization epitopes.
    Blondel B; Crainic R; Dufraisse G; Candréa A; Horaud F
    Dev Biol Stand; 1985; 60():337-42. PubMed ID: 2412917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Establishment of 25 hybridomas secreting monoclonal antibodies against type 1 polio viruses (Sabin strain) and their application in antigenic analysis].
    Gu FZ; Mu GF; Wang YA
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Jun; 6(3):157-61. PubMed ID: 6098380
    [No Abstract]   [Full Text] [Related]  

  • 7. Antigenic modification of attenuated Sabin type 1 poliovirus by in vitro passages at supraoptimal temperatures.
    Crainic R; Blondel B; Candréa A; Dufraisse G; Horaud F
    Dev Biol Stand; 1985; 60():343-7. PubMed ID: 2995173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic sites of poliovirus type 3 eliciting IgA monoclonal antibodies in orally immunized mice.
    Buttinelli G; Ruggeri FM; Marturano J; Novello F; Donati V; Fiore L
    Virology; 2001 Mar; 281(2):265-71. PubMed ID: 11277698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of antipoliovirus monoclonal antibodies as an improved safety test for oral live poliomyelitis vaccine.
    Horie H; Sato M; Doi Y; Hashizume S
    Vaccine; 1996 Jan; 14(1):35-41. PubMed ID: 8821647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A hybridoma cell line secreting antibody to poliovirus type 3 D-antigen: detection in virus harvest of two D-antigen populations.
    Ferguson M; Schild GC; Minor PD; Yates PJ; Spitz M
    J Gen Virol; 1981 Jun; 54(Pt 2):437-42. PubMed ID: 6270261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitation of D antigen content in inactivated poliovirus vaccine derived from wild-type or sabin strains.
    Sawyer LA; McInnis J; Albrecht P
    Biologicals; 1993 Jun; 21(2):169-77. PubMed ID: 8297601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies specific for the Sabin vaccine strain of poliovirus 3.
    Ferguson M; Yi-hua Q; Minor PD; Magrath DI; Spitz M; Schild GC
    Lancet; 1982 Jul; 2(8290):122-4. PubMed ID: 6123838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural variation of poliovirus neutralization epitopes.
    Crainic R; Couillin P; Blondel B; Cabau N; Boué A; Horodniceanu F
    Infect Immun; 1983 Sep; 41(3):1217-25. PubMed ID: 6193066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WHO collaborative study on the use of monoclonal antibodies for the intratypic differentiation of poliovirus strains.
    Ferguson M; Magrath DI; Minor PD; Schild GC
    Bull World Health Organ; 1986; 64(2):239-46. PubMed ID: 3017595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic analysis of poliovirus type 3 using monoclonal antibodies.
    Ferguson M; Minor PD; Magrath DI; Schild GC
    Dev Biol Stand; 1984; 57():151-5. PubMed ID: 6098495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of neutralizing antibody in mice against poliovirus type II with monoclonal anti-idiotypic antibody.
    Uytdehaag FG; Osterhaus AD
    J Immunol; 1985 Feb; 134(2):1225-9. PubMed ID: 2981264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production and characterization of neutralizing monoclonal antibodies against poliovirus type 1, 2, and 3.
    Payment P; Trudel M; Thibodeau L; Lecomte J
    Can J Microbiol; 1989 May; 35(5):550-3. PubMed ID: 2545322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies of four different specificities for neutralization of type 1 polioviruses.
    Humphrey DD; Kew OM; Feorino PM
    Infect Immun; 1982 May; 36(2):841-3. PubMed ID: 6282759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation of poliovirus type I isolates in the 1982 epidemic from Sabin-I strain by antigenic and temperature markers.
    Lee CN; Kao CL; Lee CY
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Feb; 20(1):80-8. PubMed ID: 3036431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal trypsin can significantly modify antigenic properties of polioviruses: implications for the use of inactivated poliovirus vaccine.
    Roivainen M; Hovi T
    J Virol; 1987 Dec; 61(12):3749-53. PubMed ID: 2824812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.